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ABSTRACT: Peripheral nerve injuries affect a large proportion of
the global population, often causing signiﬁcant morbidity and loss
of function. Current treatment strategies include the use of
implantable nerve guide conduits (NGC’s) to direct regenerating
axons between the proximal and distal ends of the nerve gap.
However, NGC’s are limited in their effectiveness at promoting
regeneration Current NGCs are not suitable as substrates for
supporting either neuronal or Schwann cell growth, as they lack an
architecture similar to that of the native extracellular matrix (ECM)
of the nerve. The aim of this study was to create an acellular porcine
peripheral nerve using a novel decellularisation protocol, in order to
eliminate the immunogenic cellular components of the tissue, while
preserving the three-dimensional histoarchitecture and ECM
components. Porcine peripheral nerve (sciatic branches were
decellularised using a low concentration (0.1%; w/v) sodium
dodecyl sulphate in conjunction with hypotonic buffers and
protease inhibitors, and then sterilised using 0.1% (v/v) peracetic
acid. Quantitative and qualitative analysis revealed a 95% (w/w)
reduction in DNA content as well as preservation of the nerve
fascicles and connective tissue. Acellular nerves were shown to have
retained key ECM components such as collagen, laminin and
ﬁbronectin. Slow strain rate to failure testing demonstrated the
biomechanical properties of acellular nerves to be comparable to
fresh controls. In conclusion, we report the production of a
biocompatible, biomechanically functional acellular scaffold, which
may have use in peripheral nerve repair.
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Introduction
The nervous system is one of the most highly organised biological
systems, and is subdivided into the central nervous system (CNS)
and peripheral nervous system (PNS). Injuries to the peripheral
nerves are common and debilitating, affecting 2.8% of trauma
patients (Noble et al., 1998). The microenvironment surrounding an
injury site in the PNS is usually permissive to axonal regeneration.
Over relatively short distances (less than 5mm), axons can
spontaneously regenerate (Rangappa et al., 2000). While the
capacity of regeneration is a possibility for PNS injuries, complete
functional recovery is infrequent and often misdirected in defects
greater than 30mm (Moore et al., 2009).
Current management of peripheral nerve injury includes direct
end-to-end suturing of the damaged nerve ends or the use of an
autologous nerve graft. Suturing is limited to a few millimetres for
the repair of small defects or gaps. For longer nerve gaps this
approach is not desirable because it has been demonstrated that any
tension introduced into the nerve cable inhibits nerve regeneration
(Millesi, 1982). Autologous nerve grafting remains the current gold
standard surgical intervention for larger nerve defects (>30mm).
A dispensable nerve, usually the sural nerve (which has sensory
function), is harvested and used to bridge the defect. Multiple
segments are placed side by side, without tension to match the
width of the injured nerve. Sensory nerves are used since they
are deemed to be more expendable than motor nerves. Nonetheless,
donor site morbidity and multiple surgeries are signiﬁcant and
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avoidance of this necessity in treatment is desirable. Moreover it has
been reported that the functional recovery using an autograft is at
best 80% (Schmidt and Leach, 2003).
It has been widely demonstrated that the physical guidance of
axons is a vital component of nerve repair and regeneration
(€Ochsner et al., 2010). Current research focuses on entubulating
opposing nerve stumps of the severed nerve using a Nerve Guidance
Conduit (NGC) (Kehoe et al., 2012). NGC’s are manufactured from
either synthetic, that is, polycapralactone (PCL) and polyclycolic
acid (PGA) or natural materials such as collagen (Evans, 2001;
Heath and Rutkowski, 1998; Pﬁster et al., 2011) and can be used for
defects between 20 and 30mm, and importantly eliminates the
need for grafting (Bell and Haycock, 2012).
The Food and Drug Administration (FDA) and Conformit Europe
(CE) have approved a relatively small number of NGCs (NeuraGen
1
,
Neurolac
1
, and Neurotube
1
) for clinical peripheral nerve
repair (Meek and Coert, 2008). In clinical trials, NGCs have been
reported to have a comparable efﬁcacy to autologous grafting in
defects up to 20mm (Meek and Coert, 2008). However, limitations
of conduits include the production of acidic degradation products
and high rates of degradation, which have been observed in
Neurotube
1
; high rigidity reported in Neurolac
1
, which have caused
needle breakages when suturing the NGC in place, and slow
degradation rate in NeuraGen
1
(up to 48 months in vivo which can
lead to nerve compression (Meek and Coert, 2008). For nerve
defects greater than 30mm, autografts are still considered as the
gold standard, and NGCs are not considered as effective for these
gap sizes.
It has been hypothesised that the limited efﬁcacy of NGCs in
promoting nerve regeneration over longer distances is due to the
lack of a suitable surface topography (Spivey et al., 2012). Peripheral
nerves consist of axons held together by the ECM and basal lamina
to form an atomically deﬁned trunk and nerve fascicles. Evidence
suggests that the basal lamina and ECM play important roles in
both the development and repair of the PNS (Spivey et al., 2012).
The ECM has an ability to inﬂuence cell morphology, phenotype
and function through cell-substrate interaction, as well as
promoting cell–cell interactions. The basal lamina forms a close
relationship with regenerating nerve ﬁbres. A study by Ide et al.
(1983) concluded that the basal lamina provides a pathway not only
for the initial axonal elongation but also for the maintenance and
maturation of regenerating axons (Ide et al., 1983).
An alternative approach is therefore attractive for creating nerve
grafts which replicates the natural nerve architecture at a
subcellular level in order to promote nerve regeneration over
greater distances (>30mm). One way of achieving this is through
tissue decellularisation. This involves the removal of immunogenic
components from the chosen tissue while retaining the 3D structure
and ECMcomponents. The rationale behind decellularisation is that
ECM components are widely conserved across species and are also
not adversely immunogenic.
A number of methods have been documented for the preparation
of acellular nerve grafts from donor nerve tissue. gulThe most
commonly utilised method involves a combination of physical,
chemical, and enzymatic treatments. Commonly, physical treat-
ments such as snap freezing is applied at the beginning of the
decellularisation process to disrupt the cell membrane and lyse the
cells. This is then followed by chemical and enzymatic treatments.
Chemical treatments include detergents (ionic, non-ionic, and
zwitterionic); acid and alkaline treatments; hypo and hypertonic
solutions and chelating agents such as EDTA. These treatments are
used to solubilise both cytoplasmic proteins and nuclear cellular
membranes. Additional enzymatic treatments such as nucleases are
added for the removal of the cellular debris (Crapo et al., 2011;
Gilbert et al., 2006). During the decellularisation process proteases
are released from lysed cells, which can cause damage to the native
ECM ultrastructure. Protease inhibitors such as Aprotinin are
therefore added to solutions. Sterilisation methods for acellular
tissue include incubation in acids or solvents, ethylene oxide
exposure, gamma irradiation or electron beam irradiation (Hodde
and Hiles, 2002).
AxoGen is the only company to have a clinically approved
decellularised nerve graft on the market (Avance
1
Nerve Graft),
which uses utilises decellularised human donor allografts. Current
data suggests the Avance
1
Nerve Graft implants increases
reinnervation and improves clinical outcome when compared to
commercial available NGCs (Whitlock et al., 2009). A multicentre
study using Avance
1
Nerve Graft showed that out of all other
commercially available products it was the only one that had the
ability to support repair in motor, sensory and mixed nerve types,
as well as having the ability to repair both short (5–14mm),
medium (15–29mm), and long (30–50mm) nerve gaps, making it
comparable to an autograft (Brooks et al., 2012). However supply of
human nerves for decellularisation and risk of product supply and
disease transmission, may limit clinical potential.
The use of xenogeneic tissue offers an attractive alternative route
to that of human tissue. A number of porcine organs are
anatomically similar to human (e.g., the heart), but in particular the
peripheral nerves, which contain an epineurium, perineurium and
endoneurial microstructure, together with similar ECM organiza-
tion and composition (Zilic et al., 2015). A number of advantages
are therefore evident if regarding porcine nerve tissue for
therapeutic purposes. We hypothesise that porcine peripheral
nerves can provide a suitable level of physical guidance and
regenerative support as nerve autografts. The aim of this study was
therefore to develop a protocol for the decellularisation of porcine
peripheral nerves. The efﬁcacy of decellularisation was determined
using histological, immunohistochemical and biochemical techni-
ques. In addition, the biocompatibility and biomechanical
properties of acellular nerves were investigated to establish
potential clinical utility.
Methods
Procurement of Porcine Peripheral Nerves
Large White Yorkshire pigs (24–26 weeks old) were obtained from a
local abattoir (J. Penny, Leeds, United Kingdom) within 24 h of
slaughter. The tibial and peroneal nerves were dissected from the
posterior compartment of the porcine leg, branching out from the
sciatic nerve (as described in [Zilic et al., 2015]). The tibial nerve
was observed to travel in the posterior section of the leg and the
peroneal nerve in the lateral section. Excess fat and connective
tissue was dissected from the nerve samples and tissues washed
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three times in phosphate buffered saline solution (PBS; Oxoid,
Basingstoke, U.K.), containing 0.1% (w/v) ethylene diamine tetra
acetic acid (EDTA; VWRi) to remove excess blood. Tissues were
then stored at 80C on Phosphate Buffered Saline (PBS)
moistened ﬁlter paper for future use. All nerves were 150–300mm
in length and varied in diameter, with the peroneal nerve ranging
from 2–3mm and the tibial nerve ranging from 2–4mm.
[Throughout this paper the peroneal and tibial nerves will be
referred to collectively as the “sciatic branches” unless otherwise
stated.]
Decellularisation
The decellularisation of porcine peripheral nerves was based on
modiﬁcation of a procedure described by (Wilshaw et al., 2012). The
nerves were subjected to a freeze-thaw cycle and individually
processed in 250mL of solution. Nerves were subjected to two
cycles of hypotonic buffer (10mM TRIS-HCl; pH 8.0) and
hypotonic buffer containing 0.1% (w/v) sodium dodecyl
sulphate (SDS; Sigma) with agitation in the presence of Aprotinin
(10 kIU/mL; Nordic Pharma) and EDTA (0.1%; w/v; VWRi). Each
nerve was washed in PBS three times for 30min with agitation.
Each nerve was subsequently treated using Benzonase (1 U/mL;
EMD Biosciences in buffer, 50mM TRIS-HCl, 1 mM MgCl2;
Sigma; pH 7.5) for 3 h at 37C with gentle agitation. Each nerve
was then incubated in hypertonic buffer (1.5M NaCl in 50mM
TRIS-HCl, pH 7.6) with agitation. A sterilisation step, consisting
of 0.1% (v/v) peracetic acid (Sigma, Poole, Dorset, U.K.) in PBS
for 3 h at room temperature (20–25C) with agitation was
incorporated. Nerves were then washed three times in PBS at
4C for 30min each with agitation followed by a ﬁnal 48 h wash in
PBS at 4C.
Biological Evaluation of Peripheral Nerves
Segments (10mm) were taken from either the proximal, distal or
central regions (n¼ 3) of each nerve and ﬁxed in 3.7% (v/v)
formaldehyde prior to analysis. Acellular nerves were compared to
native control nerves (n¼ 6). Samples were dehydrated in an
automated tissue processer (Leica TP1020) before being embedded
into parafﬁn wax (VWRi) to form histology blocks. Transverse
sections (6mm) of each nerve sample were cut using a rotary
microtome (Leica RM 2125 RTF) and transferred onto slides.
Sections were de-waxed and dehydrated before staining by
submerging sequentially in xylene (2 10min), 100% ethanol
(3 2min), 70% (v/v) ethanol (2 min), and then water (3min).
Sections were viewed using an Olympus BX51 microscope and
images captured using an Olympus XC50 digital camera (with
Olympus Soft Imaging Solutions software).
Haematoxylin and Eosin Staining
Haematoxylin & eosin (H&E; Raymond A Lamb Ltd., U.K.) staining
of native and acellular nerve segments was used to evaluate tissue
histoarchitecture. Samples were immersed in Harris haematoxylin
(Thermo Fisher Scientiﬁc Ltd., U.K) (1min) and rinsed under tap
water for blueing (3min). Slides were then immersed into eosin Y
(VWR International) (3min), dehydrated, cleared and mounted
using DPX mountant before being viewed under Kohler
illumination.
Nuclei Staining
Acellular and native nerve slides were immersed into a 300nM DAPI
working solution (20mL DAPI [Sigma] in 200mL PBS) and
incubated for 10min in the dark. Sections were then washed with
PBS three times for 10min each in the dark. The sections were
then mounted with a glass coverslip and DPX mountant and
stored in the dark until viewed. Sections were imaged using an
upright epiﬂuorescent microscope and samples observed under
lex¼ 350 nm/lem¼460 nm. Micrograph images were captured
using a digital camera (Image pro Plus v 5.1).
Staining for Collagen and Elastin
Staining for collagen and elastin was carried out on the same slide.
Samples were immersed in 5% (w/v) potassium permanganate
(Thermo Fisher Scientiﬁc Ltd.) for 5min and then rinsed with
distilled water, and then submerged into 1% (w/v) oxalic acid for
2min, rinsed with water for a further 4min and submerged in 95%
(v/v) ethanol and 70% (v/v) ethanol for 1min, respectively. Samples
were then stained for 1 h with Millers’ stain (Raymond A Lamb Ltd.)
and rinsed with 95% (v/v) ethanol, 70% (v/v) ethanol and distilled
water respectively. Samples were subsequently stained withWeigert’s
iron haematoxylin (Atom Scientiﬁc, U.K.) for 10min and rinsed
with distilled water for 30 s for blueing. Samples were then stained
with 0.1% (w/v) Picro-Sirius Red (Sigma–Aldrich, Poole, Dorset,
U.K.) for 1 h, rinsed with distilled water and blot dried. Sections
were dehydrated, cleared and mounted using DPX mountant before
being viewed under Kohler and polarised illumination.
Staining Sulphated Glycosaminoglycans
Alcian Blue Periodic Acid Schiff ’s stain (ABPAS; Raymond A Lamb
Ltd.) was used to localise sulphated glycosaminoglycans (GAGs).
Sampleswere immersed into 1% (w/v) ABPAS (pH 2.5) for 1min and
rinsed with distilled water. The slides were then immersed in 0.1%
(w/v) periodic acid solution (Sigma) for 5min and rinsed three times
with distilledwater. The slideswere then immersed in Schiff ’s reagent
(Sigma) for 15min and rinsed with distilled water for 5min; cell
nuclei were stained with haematoxylin (Gills Number 3 haemato-
xylin; Sigma) for 90 s. Samples were blued using tap water,
dehydrated, cleared and mounted using DPX mountant before being
viewed using an upright microscope under Kohler illumination.
Immunolabelling for Laminin and Fibronectin
Tissue sections were permeabilised with 0.1% (v/v) Triton X-100
(Sigma) diluted in PBS for 20min. Samples were then incubatedwith
7.5% (w/v) bovine serum albumin (BSA; Sigma) diluted in PBS at
room temperature for 60min, followed by washing once with 1% (w/
v) BSA in PBS. Omission of the primary antibody served as a negative
control. Native porcine nerve served as a positive control; an isotype
control antibody (IgG1, Dako) was used to verify antibody speciﬁcity.
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Laminin
Nerve tissue samples were incubated with primary rabbit anti-
laminin antibody (polyclonal IgG; 0.01mg/mL; Sigma, LN393, in
1% v/v; BSA) at 1:200 v/v dilution) at 4C overnight, followed by
washing three times with PBS for 5min and then incubated with
secondary FITC conjugated anti-rabbit IgG (Abcam U.K., ab97050,
1:100 v/v) at room temperature in the dark for 1 h. Each section was
washed three times with PBS for 5min and counterstained with
300 nM DAPI in PBS and incubated for 20min in the dark at
room temperature. Sections were ﬁnally washed three times with
PBS for 5min and imaged using a Zeiss LSM510 META upright/
inverted confocal microscopes (xenon arc lamp to excite FITC;
lex¼ 495 nm/lem¼ 515 nm). Nuclei were visualised using lex¼
350 nm/lem¼ 460 nm).
Fibronectin
Nerve samples were incubated with a primary anti-ﬁbronectin
rabbit polyclonal antibody (Sigma; F3648; in 1% w/v; BSA at
1:400 v/v dilution) at 4C overnight. Each sample was washed
three times with PBS for 5min each and incubated with secondary
FITC-conjugated anti-rabbit IgG (1:100 v/v dilution) at room
temperature in the dark for 1 h. Sections were subsequently washed
three times with PBS for 5min each and counterstained with
300 nM DAPI for 20min in the dark at room temperature. Samples
were then washed three times with PBS for 5min and imaged
using the confocal microscope an upright / inverted Zeiss LSM510
META confocal microscope (xenon arc lamp to excite FITC
(lex¼ 495 nm/lem¼ 515 nm). Nuclei were visualised using (lex¼
350 nm/lem¼ 460 nm).
Biochemical Assays
Samples of the native (n¼ 3) and acellular porcine sciatic branches
(n¼ 3) were lyophilized to a constant weight prior to biochemical
assay for DNA, collagen and sulphated sugars content. Each sample
consisting of 100mg tissue were macerated with a scalpel blade and
placed in a sterile 1.5 mL microcentrifuge tube. The samples were
then freeze-dried; the mass of each sample was recorded daily until
a consistent weight was achieved (approximately 25mg).
DNA Quantification
DNA quantiﬁcation was used to determine the total remaining DNA
in porcine peripheral (sciatic branches) nerves following
decellularisation by comparing the DNA levels in decellularised
and fresh tissue. DNA extraction was carried out using the DNeasy
blood and tissue kit (QIAgen 69504). Buffer ATL (360mL) and
40mL proteinase K (>600mAU/mL), both from the QIAgen kit,
were mixed with the macerated freeze-dried tissue by vortexing and
incubating at 56C for 3 h or until the tissue was completely
digested. Pulse vortexing (5–10 s) was performed every 30min to
disperse the sample. Each sample was vortexed for 15 s at the end of
the incubation. Buffer AL (400mL) from the QIAgen kit was added
to the sample, and mixed thoroughly immediately by vortexing and
400mL of ethanol (100%; v/v) was added, and mixed thoroughly
immediately by vortexing.
Each sample was transferred to a separate DNeasy Mini spin
column placed in a 2mL collection tube, and centrifuged at 6,000g
for 1 min. The ﬂow-through was discarded together with the
collection tube. The DNeasy Mini spin column was placed in a fresh
2mL collection tube, and Buffer AW1 (500mL) was added to the
column. The DNeasy membrane at the bottom of the DNeasy Mini
spin column was dried by centrifuging at 15,000g for 3 min. The
ﬂow-through was discarded together with the collection tube.
The DNeasy Mini spin column was placed in a clean 1.5mL
microcentrifuge tube, and Buffer AE (200mL) was added directly to
the centre of the DNeasy membrane. After incubation for 1min, the
1.5 mL microcentrifuge tube was centrifuged for 1min at 6,000g to
elute. The extracted DNAwas in Buffer AE in the ﬂow-through. The
DNeasy Mini spin column was discarded. The extracted DNA was
subjected to quantiﬁcation immediately or stored at 20C until
needed.
The concentration of extracted DNAwas determined spectropho-
metrically using a Nanodrop spectrophotometer (Labtech). Buffer
AE (2mL) was used as a blank. Extracted DNA sample (2mL) was
loaded onto the Nanodrop, and the absorbance was determined at
260 nm. Three readings were taken for each sample, and the mean
was considered as the absorbance of the sample. The DNA
concentration (ng/mL) in the sample was directly displayed in the
Nanodrop software. This concentration was used to calculate the
DNA weight/tissue weight (mg/mg) according to:
DNA weight=tissue weight ðmg=mgÞ ¼ C  200
25  1; 000
where C represents the DNA concentration in the Buffer AE
(ng/mL). The volume of the Buffer AE containing extracted DNA
was 200mL. The total weight for each tissue sample was 25mg.
Hydroxyproline Assay
A hydroxyproline assay was carried out to determine the total
remaining collagen remaining in porcine peripheral (sciatic
branches) nerves following decellularisation. The procedure
adopted was based on the method described by Woessner and
subsequently modiﬁed by (Edwards and O’Brien, 1980). This assay
is based on the oxidation of hydroxyproline by chloramine—T
(sodium N-chloro-p-toluenesulfonamide; [Sigma]) which reacts
with p-dimethylaminobenzaldehyde (Sigma) to form a chromo-
phore that can be measured at 570 nm (Stegemann and Stalder,
1967). Prior to the assay the tissue samples were hydrolysed
(hydrolysis of peptide bound hydroxyproline) in 5mL of 6M
hydrochloric acid (HCL; VWRi) at 120C for 4 h. For the assay a
series of known concentrations was made up using primary and
secondary standards. The primary standard was prepared by
adding 25mg trans-4-hydroxyproline [Sigma] in 25mL assay
buffer (13.3 g citric acid [VWRi], 3.2 mL glacial acetic acid [VWRi],
32 g sodium acetate [Thermo Fisher], 9.1 g sodium hydroxide
[VWRi] and 80mL propan-1-ol [VWRi] in 400mL distilled water
with pH adjusted to 6–6.5 using 6M HCL. The secondary standard
was prepared by diluting 1mL of the primary standard in 9mL
assay buffer. Tissue samples were diluted 1:20 using assay buffer,
standards were used directly in assay buffer and blank samples used
50mL of assay buffer.
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Fifty microliters of each standard and acid hydrolysed test
solutions (diluted 1:20 in assay buffer so that readings were within
the range of the assay) were added to a clear ﬂat-bottomed 96 well
plate. One hundred microliters Chloramine T solution (1.41 g
chloramine T [Sigma] in 100mL distilled water) was added to
each well and the plate was shaken for 5min at 60 rpm on a
shaker (Grant). 100mL Ehrlich’s reagent (7.5 g p-dimethylamino-
benzaldehyde; Sigma), 30mL propan-1-ol (VWRi), 13.4 mL
60% (v/v) perechloric acid [BDH] and 6.6 mL distilled water)
was added to each well and the plate was incubated at 60C for
45min.
The plate was read at 570 nm using a micro plate spectro-
photometer (Multiskan spectrum; Thermo Scientiﬁc). The blank
values (assay buffer) were subtracted from all standards and tissue
samples and a standard curve of hydroxyproline concentration
against absorbance was determined by interpolation from a trans-
4-hydroxy-L-proline standard curve. The total collagen content was
calculated by using a hydroxyproline to collagen ratio of 1: 7.69
(Ignat’eva et al., 2007).
Sulphated Sugar Assay
A modiﬁed GAG assay according to (Farndale et al., 1986) was used
to quantify the amount of sulphated GAGs present in porcine
peripheral (sciatic branches) nerves following decellularisation.
The assay is based on changes in the absorption spectrum of
the cationic dye 1,9-dimethylmethylene blue (DMB dye; Sigma)
when bound to sulfated GAGs to form a complex (Farndale
et al., 1986). The amount of GAGs present was determined by
comparing the proteoglycan levels in the native tissue to the
acellular tissue.
Protease papain was used to digest the freeze-dried tissue
samples by adding 5mL of 50 IU/mL papain digestion solution
(1,250 units of papain; [Sigma] in 25mL of digestion buffer (5 mM
L-cysteine hydrochloride; [Sigma], 5 mM Na2EDTA; Thermo
Fisher). Samples were incubated for 36–48 h in an oven at 60C
and diluted 1:50 in GAG assay buffer (68.5mL of 0.1 M sodium
di-hydrogen orthophosphate (VWRi) and 31.5 mL 0.1M di-sodium
hydrogen orthophosphate (VWRi) adjusted to pH 6.8) so that the
absorbance of the unknown falls within the linear region of the
standard curve.
GAG assay standards were prepared by diluting the primary
standard (10mg chondroitin sulphate B; [Sigma] in 10mL GAG
assay buffer) to known 40mL of each standards, blank and tissue
samples were added to a clear ﬂat-bottomed 96 well plate and
250mL of DMB dye solution (0.008mg 1,9 dimethylene blue;
[Sigma] in 2.5 mL ethanol; [VWRi], 1 mL of formic acid;
[Sigma[and 1 g of sodium formate; [VWRi]; volume made up to
500mL using distilled water and pH adjusted to 3.0) was added to
each well and placed for 2min on a plate rocker (Grant). Sample
optical densities were measured using a micro plate spectropho-
tometer (Multiskan spectrum; Thermo Scientiﬁc) at 525 nm. The
blank values (assay buffer) were subtracted from all standards and
tissue samples and a standard curve of chondroitin sulphate B
concentration against absorbance was created using GraphPad
Prism. The unknown values were interpolated using a linear
regression of the standard curve.
Biocompatibility of Acellular Nerve
A cytotoxicity assay was undertaken to assess whether the acellular
nerves contained any residual SDS, which may prove cytotoxic to
cells. Two different cell lines were used in this assay (detailed
below). Cyanoacrylate glue (Sigma) and collagen type I (rat tail;
Sigma C3867) were used as positive and negative controls
respectively.
Cell Culture
Human dermal ﬁbroblasts (isolated from donor skin of
abdominoplasty or breast reduction; donated form patients of
the Royal Hallamshire Hospital, Shefﬁeld, U.K; in accordance with
local ethically approved NHS guidelines and under U.K. HTA
Research Tissue Bank license number 12,179 regulations) and
primary rat Schwann cells (isolated using a selective D-valine
method [Kaewkhaw et al., 2012]). Human dermal ﬁbroblasts were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM, Biosera)
containing 10% (v/v) foetal calf serum (FCS; Biosera), 100 U/mL
penicillin (Sigma), 100mg/mL streptomycin (Sigma), 0.25mg/mL
amphotericin (Sigma), and 2mM L-glutamine (Sigma) at 37C in
5% (v/v) CO2. Primary rat Schwann cells cells were grown in
T75 cm2 ﬂasks and cultured in MEM D-Valine medium (Labtech
International Ltd.) supplemented with 10% (v/v) FCS, L-glutamine
(1%; v/v), amphotericin B (0.25%; v/v), penicillin–streptomycin
(1%; v/v) and forskolin (25mM; Sigma). Cells were incubated at
37 C in a humidiﬁed atmosphere containing 5% (v/v) CO2. The
culture medium was changed once every 2 days.
Upon conﬂuency both cell types were passaged by removing the
culture medium and washed twice with PBS. 5 mL of 0.25% (w/v)
Trypsin-EDTAwas added to ﬂask and left to incubate for 2–3min at
37C in 5% (v/v) CO2 until cells detached from the surface of the
ﬂask. 5 mL of DMEMcontaining 10% (v/v) serumwas then added to
inactivate the trypsin and the cell suspension was transferred to a
50mL centrifuge tube and centrifuged at 1,000g for 5 min. The
supernatant was discarded and the cell pellet resuspended in 5mL
of supplemented DMEM. One milliliter of the cell suspension was
then added to a new T75 ﬂask and a further 9mL of supplemented
DMEM was added to the ﬂask. The ﬂask of cells was then incubated
at 37C in 5% (v/v) CO2.
Contact Cytotoxicity Assay
Samples of 5mm2 acellular peripheral nerves were attached to the
center of six-well tissue culture plates using collagen type I. Human
dermal ﬁbroblasts and primary rat Schwann cells were seeded into
each well at a density of 5 105 cells per well and incubated at 37C
in 5% CO2 (v/v) for 48 h. Following incubation the culture medium
discarded and the wells washed with PBS containing calcium and
magnesium and ﬁxed with 3.7% (v/v) neutral buffered formalin
(Raymond A Lamb) for 10min. Each well was stained with Giemsa
solution (VWR) for 5min. Each well was gently rinsed with tap
water until running clear and left to air dry. The plates were
examined under phase contrast microscopy using an inverted
Olympus IX71 microscope. Any changes to cell morphology and
conﬂuency were recorded. All images were captured digitally.
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Biomechanical Properties of Porcine Peripheral Nerves
Freshly dissected peroneal (n¼ 5), tibial (n¼ 10) and acellular
peroneal (n¼ 3) and tibial nerve (n¼ 4) samples were cut to
10 mm in length and their diameter measured using a calliper.
Hydrated samples were clamped into a tensiometer (BOSE
Electroforce test instruments, Minnesota, USA; using a 450 N
load cell). A single pull to failure test was carried out at a speed of
0.1 mm/s. The ﬁrst failure point or plateau was used to calculate
the ultimate tensile strength (UTS), and the initial linear gradient
was used to calculate the Young’s modulus (YM). For all specimens
the mean ultimate stress, mean ultimate strain and Young’s
modulus were determined from the initial length and area of the
specimens.
Data Analysis
All numerical values are shown as mean values 95% conﬁdence
limits. Statistical signiﬁcance was assessed by the T-method and
P-values of <0.05 were considered signiﬁcant.
Results and Discussion
The aim of this study was to develop a process for the
decellularisation of porcine peripheral nerve, with minimal effect
on the tissue properties. The major ﬁnding of the study identiﬁed a
combination of low concentration SDS, hypotonic buffers and
nuclease enzymes that can effectively remove cells from porcine
tissue while retaining its endoneurial structure and important ECM
components. The study also showed that the acellular nerve was not
cytotoxic to cells and that the nerve retained its mechanical
properties.
Various methods exist for preparing acellular nerve grafts from
donor nerve tissue. The most commonly utilised methods for
decellularisation of nerve tissue include cold preservation; (Evans
et al., 1998), thermal (Ide et al., 1998; Gulati, 1988) radiation (Hiles,
1972) and detergent based chemical treatments (Hudson et al.,
2004; Sondell et al., 1998).
Prolonged cold preservation of donor nerve tissue have resulted
in the preservation of native Schwann cell basal laminae and nerve
ECM. The drawback however was the long processing times
(approximately seven weeks) as well as poor mechanical properties
of the decellularised graft (Evans et al., 1998).
Thermal decellularisation subjects the nerve tissue to repeated
freeze-thaw cycles, rendering the graft non-immunogenic by lysing
cells (Gulati and Cole, 1994; Zalewski and Gulati, 1982). This
process has been adapted and used successfully to produce
acellular grafts, which were subsequently reseeded with Schwann
cells (and/or ﬁbroblasts). Studies have shown the grafts to
effectively support axon regeneration in both central and peripheral
nervous systems (Cui et al., 2003; Godinho et al., 2013; Hu et al.,
2005, 2007).
There have however been reports that the freeze-thawing process
fails to remove the cell debris from the tissue, in addition to
fracturing the basal laminae that surround the axons (Hudson et al.,
2004). In vivo studies have demonstrated cellular remnants left
behind from this process have led to cellular invasion in the form of
Schwann cells and macrophages invading the basal lamina to clear
away the debris. This in turn delays the regenerative process and
further damages the basal lamina (Danielsen et al., 1995; Osawa
et al., 1990; Pollard and Fitzpatrick, 1973).
Radiation has also been used as a decellularisation technique for
nerve tissue. Studies have shown that this process does not damage
the tissue morphology (Marmor, 1964). Nevertheless similar to
thermal decellularisation, cellular debris still remains inside the
basal laminae causing cellular invasion post implantation (Hudson
et al., 2004).
Detergent processing techniques were developed to avoid the
destructive effects of freeze thawing on the tissue ultrastructure,
although freeze-thawing methods are identiﬁed as producing non-
immunogenic segments (Gulati, 1988). Over a number of years
detergent decellularisation processes have been optimised by using
less aggressive chemical treatments with a method developed by
Sondell et al. (1998) and colleagues representing the predominant
method of chemical decellularisation for nerve tissue. Low
concentration SDS has previously been used to decellularise
various soft tissues including arteries (Wilshaw et al., 2012); liver
(Uygun et al., 2010); heart valves (Korossis et al., 2002) and veins
(Schaner et al., 2004).
The decellularisation procedure developed used a combination of
chemical and enzymatic treatments, based on the process
developed by (Wilshaw et al., 2012) and modiﬁed for porcine
peripheral nerve. The ﬁrst step of the process was a single freeze-
thaw cycle to open up the tissue ECM, increasing the susceptibility
of subsequent decellularisation reagents. The nerves were
disinfected and then exposed to a solution of 200mM EDTA.
EDTA chelates divalent metal ions (in particular Ca2þ), which
disrupts cell attachment to the ECM by interfering with the integrin
secondary structure and consequent binding (McFetridge et al.,
2004). This was followed by sequential incubation in hypotonic
TRIS buffer to lyse the neuronal and Schwann cells, 0.1% (w/v) SDS
in hypotonic buffer plus protease inhibitors (for inhibition of
endogenous proteinases) to solubilise cell fragments. Benzonase, a
nuclease enzyme was used to catalyse the hydrolysis of both
deoxyribonucleated (DNA) and ribonucleated (RNA) chains.
Disinfection of the tissue was carried out using 0.1% (v/v)
peracetic acid for 3 h followed by extensive washing in PBS to
remove residual SDS. Peracetic acid is a commonly used
disinfection agent and also acts as a decellularisation agent
(Gilbert et al., 2006). Peracetic acid is also widely used to disinfect
surgical instruments due to excellent anti-viral properties (Rutala
and Weber, 2004). SDS is widely considered to be a good
decellularisation agent and has been shown to effectively remove
DNA remnants and cytoplasmic proteins, however at high
concentrations there can be some disruption to the ECM
ultrastructure as well as loss of collagen and GAGs was observed
(Wilshaw et al., 2012).
Studies have shown the most successful nerve grafts, such as
those developed by Sondell et al. (1998), which have demonstrated
nerve regeneration are unable to match the regeneration rates
observed with autografts, even with incorporation of Schwann cells
(Frerichs et al., 2002). It has been hypothesised that the inadequate
preservation of the ECM structure in these detergent-treated
decellularised graft is a contributing factor to this failure (Hudson
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et al., 2004). Studies using milder detergents have demonstrated
superior preservation of native ECM and equivalent levels of
decellularisation compared with previous chemical processing
techniques (Hudson et al., 2004). The protocol used in this present
study uses a ten-fold lower concentration of SDS (0.1% w/v). It has
been suggested by Booth et al. (2002) that the damage to the matrix
reported in previous studies may have been caused indirectly by the
proteases released as a result of cell lysis, and not the SDS directly
(Booth et al., 2002), hence the incorporation of protease inhibitors
into the protocol described in the current study.
Histological, immunohistochemical and biochemical characteri-
sation of the acellular nerve were carried out to determine if the
tissue maintained a native histioarchitecture and retained key ECM
components. In this study biochemical quantiﬁcation assays of the
ECM components as well as the DNA content of the acellular nerve
were undertaken. This combination of cellular and acellular
measurements is of particular note, as there are limited reports of
ECM and DNA quantiﬁcation in other nerve decellularisation
methods.
Histological staining demonstrated retention of native nerve
fascicles and connective tissues (Fig. 1) as well as collagen and
sulphated GAGs (Figs. 2 and 3). Collagen is an important ECM
component, constituting approximately 49% of total protein of
peripheral nerve (Bunge et al., 1989). The principal role of collagen
is to provide structural as well as mechanical support to the nerve.
Sirius Red staining did not reveal any macroscopic or microscopic
evidence of damage to collagen ﬁbres, or signiﬁcant loss in total
collagen within acellular nerves. This was conﬁrmed using a
hydroxyproline assay, which demonstrated a 6.7% reduction in total
collagen content when compared to the native nerve; this was not
deemed signiﬁcant (Table I).
Alcian Blue staining of acellular nerves showed retention of
sulphated proteoglycans (Fig. 3) however when quantiﬁed there
was a 33% reduction when compared to fresh nerves (Table I).
This signiﬁcant reduction was thought to be due to the use of
SDS. The absence of GAGs reduces the restriction on water ﬂow
and causes a reduction in the water retention of the tissue, which
also facilitates the diffusion of decellularisation solutions to
remove soluble cellular components (Gilbert et al., 2006). The loss
of GAGs has been associated with a reduction in the ultimate
tensile strength of the tissue (Partington et al., 2013). However
the biomechanical testing suggested this to have a minimal effect
on the tissue (Table II). While the loss in GAGs was signiﬁcant,
studies have indicated that chondroitin sulphate in peripheral
nerves inhibits the neurite promoting activity of laminin, and
therefore may have a negative role in nerve regeneration (Zuo
et al., 1998). A study by Krekoski et al. (2001) treated acellular rat
sciatic nerve grafts with chondroitinase ABC that inactivated
CS-GAG chains and observed an enhancement in the growth
promoting properties of the acellular scaffold. Therefore the
removal of GAGs may actually be beneﬁcial in terms of its
regeneration capacity.
Millers Elastin staining indicated a lack of elastin in fresh and
acellular nerves (Fig. 3). Peripheral nerves have visco-elastic
Figure 1. Effectiveness of the decellularisation process in the retention of tissue structure. Sections were stained with haematoxylin and eosin to identify overall
histoarchitecture. Representative histological images from the central region of native (A, B and C) and acellular (D, E and F) porcine peripheral nerves. Both native and acellular
nerve contains nerve fascicles along with the endoneurium, perineurium and epineurium connective tissue. Scale bars¼ 500 mm, 200mm and 100mm, respectively.
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properties and are able to respond to a normal range of motion of
the joints (Tassler et al., 1994). It was ﬁrst suggested that the visco-
elastic properties of the nerves are due to the elastin ﬁbres found
within the connective tissue supporting elements (Sunderland,
1968). However in this study elastin was not present in the nerves. A
reason for the lack of elastin detected in both the native and
acellular nerve may be due to the fact that both collagen and elastin
cross-stain with the traditional histochemical techniques such as
Weigert and Verhoeff-VanGiesson, therefore making it more
difﬁcult to distinguishing the presence of elastin from collagen,
however through immunolabelling, small amounts of elastin were
located in the epineurium, endoneurium and perineurium, adjacent
to the collagen ﬁbres (Tassler et al., 1994). The relatively small
percentage of elastin ﬁbres found in the nerve suggests that the
visco-elastic properties of the peripheral nerve may also be due not
only to elastin but to collagen as well. When viewed at a molecular
level It was noted that collagen ﬁbres were arranged in such a way to
allow some degree of longitudinal stretch (Ushiki and Ide, 1990). It
is thought that this specialised arrangement of layers of collagen
ﬁbres is likely to be the underlying structural component, in
conjunction with ﬂuid pressure, which provides the nerve with its
viscoelasticity (Phillips et al., 2004). It was postulated by Tassler
(1994) that elastin plays a role in the ﬁrst phase of the stress-strain
curve (strain less than 20%) and collagen thereafter, making
collagen the predominant molecule responsible for the elasticity of
the nerve (Tassler et al., 1994).
Immunohistochemical staining revealed the retention of laminin
and ﬁbronectin within the endoneurium and around the
perineurium respectively (Fig. 4). Both laminin and ﬁbronectin
are important constituents of the peripheral nerve ECM, playing
essential roles in nerve regeneration (Gao et al., 2013). Laminin,
which is located within the endoneurium and around the
perineurium (Fig. 4A–D) has many important roles in the PNS.
Along with ﬁbronectin, laminin is a major structural element of the
basement membrane as well as helping aid cell attachment (Palm
and Furcht, 1983). Cellular studies have also revealed laminin
enhances neuronal cell survival (Edgar et al., 1984) and guide
growth cones (Dodd and Jessell, 1988). A study conducted by Lein
et al. (1992) also showed that laminin had the ability to enhance
axonal growth by hippocampal neurons in culture. Fibronectin,
located around the perineurium and within the epineurium
(Fig. 4E–G) has been shown to promote Schwann cell growth and
motility, thereby enhancing regeneration of injured nerves (Ahmed
et al., 2003).
A comparative study between an acellular nerve grafts produced
by the Hudson detergent based method (sulfobetaine-10; SB-10)
and Triton X-200/sulfobetaine-16 (SB-16) and NeuraGen
1
(an FDA-
approved and commercially available type I collagen NGC) saw the
acellular graft outperforming the synthetic NGC (Hudson et al.,
2004). The study proposed that the presence of intact basal lamina
within the acellular nerve graft contributes to the enhanced
regenerating capacity to support axonal growth (Whitlock et al.,
Figure 2. Effectiveness of the decellularisation process in the removal of cells. Sections were labelled with DAPI for identification of total cell nuclei (A & D). The surrounding
green structure was the due to autofluorescence of the tissue when viewed under an upright microscope (B & E). Native nerve shows presence of cell nuclei with the endoneurium
and around the perineurium, (A–C). Acellular nerve revealed a lack of cell nuclei present within its structure. Cell nuclei are shown in blue and surrounding nerve structure in green.
Scale bar¼ 100mm.
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2009). The method developed by Hudson et al. (2004) is currently
licensed by AxoGen
1
Inc. to produce Avance
1
.
A requisite for successful decellularisation is the removal of DNA
from the tissue. Intact and fragmented DNA has the potential to
elicit an inﬂammatory response, which can lead to rejection of the
graft in vivo. Crapo et al. (2011) have proposed a decellularised graft
should have less than 50 ng double stranded DNA per mg ECM dry
weight as well as lack of visible nuclear material in tissue sections,
which can be determined using DAPI or by H&E staining.
In the present study H&E and DAPI staining showed an absence
of visible cells from tissue sections (Figs. 1 and 2) and the
tissue contained 0.037mg/mg of DNA (Table I). A study comparing
the Sondell method and Hudson method used Western blotting
to provide quantitative values for cellular removal of Myelin
Basic Protein reported values of 0.036 0.048mg/mg and
0.054 0.047mg/mg respectively (Hudson et al., 2004). When
compared to fresh nerve (1.6 0.51mg) these processes had
an overall reduction in cell content of 97.75% and 96.6%,
respectively. These results are comparable to the present study, in
which we report a 95% (w/w) DNA reduction when compared to
fresh tissue. It is important to note that the Hudson study was
carried out on the rat sciatic nerve and analysed for removal of
cellular protein while our study used porcine nerves and quantiﬁed
total DNA content (single and double stranded DNA) in the tissue.
The decellularisation process cannot eliminate total DNA from the
tissue even with the most rigorous processing methods (Badylak,
2014). Most commercially available biological scaffolds contain
trace amounts of remnant DNA, nonetheless the clinical efﬁcacy of
these devices have been largely positive (Table III).
SDS can sometimes be retained in decellularised tissues, which
can potentially be cytotoxic to cells and therefore a contact
cytotoxicity assay was performed. Both ﬁbroblast and Schwann cells
were observed microscopically and found to proliferate up to and in
physical contact with the scaffold. Both cell types maintained
Figure 3. Representative histological sections from the central region of fresh and acellular porcine peripheral nerves labelled for collagen, sulphated glycosaminoglycans
(GAGs) and elastin. Sections of native (A–C) and acellular sciatic nerve branches (D–F) stained using Sirius red (A & D), ABPAS Alcian Blue (B & E) or Millers stain (C & F). Staining
revealed collagen retention within the endoneurium, perineurium and epineurium. GAGs were found to be retained within the endoneurium. No elastin was found to be present
within native or acellular nerves. Scale bar¼ 500mm.
Table I. Biochemical characterisation of fresh and acellular porcine
nerves.
Assay
Native nerves of dry
tissue (mg/mg)
Acellular nerves of dry
tissue (mg/mg)
DNA 0.70  0.095 0.037  0.011
Collagen (hydroxyproline 7.69) 1206  195.50 1124  100.70
Sulphated proteoglycans 16.15  1.30 10.81  1.02
Data are expressed as mean (DNA n¼ 9; collagen n¼ 8, and proteoglycans
n¼ 9) 95% CI. There was a signiﬁcant reduction in DNA in the acellular nerve
(0.037mg/mg) when compared to the native nerve (0.70mg/mg). There was also a
signiﬁcant decrease in GAG content within the acellular nerves (10.81mg/mg)
when compared with native nerves (16.15mg/mg). There was no signiﬁcant
difference in the collagen content between native (1206mg/mg) and acellular nerves
(1124mg/mg).
P< 0.05.
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Table II. Biomechanical evaluation of fresh and acellular porcine nerves.
Nerve YM (MPa) UTS (MPa) Strain at UTS
Native pereoneal 7.75 0.56, n¼ 5 1.23 0.06, n¼ 5 0.23 0.04, n¼ 5
Acellular pereoneal 8.03 0.81, n¼ 3 1.81 0.30, n¼ 3 0.43 0.10, n¼ 3
Native tibial 7.43 0.53, n¼ 10 0.87 0.09, n¼ 10 0.16 0.01, n¼ 10
Acellular tibial 8.45 0.36, n¼ 4 2.69 0.51, n¼ 4 0.36 0.09, n¼ 4
YM, young’s modulus; UTS, ultimate tensile stress.
Mechanical analysis showed a signiﬁcant increase in UTS in both the acellular peroneal (1.81MPa) and tibial nerve (2.69 MPa) when compared to their native nerve
counterparts (native peroneal nerve; 1.23MPa and tibial nerve; 0.87MPa). There was a signiﬁcant increase in strain at UTS for the acellular tibial nerve (0.36) when compared to
its native counterpart (0.16). All data are expressed as mean (peroneal nerve n¼ 8; tibial nerve n¼ 11; acellular peroneal n¼ 3; and tibial nerve n¼ 4) 95% CI.
P< 0.05.
Figure 4. Representative histological images from the central region of fresh and acellular porcine peripheral nerves labelled using a monoclonal antibody against laminin
and fibronectin. Images (A–D) show retention of laminin following decellularisation (C & D) and preservation of the basal lamina when compared to native tissue (A & B). Image G
shows shows retention of fibronectin around the perineurium following decellularisation when compared to native sample (E & F). Image H is a negative control for the antibodies
raised against both fibronectin and laminin (D). Scale bar¼ 20mm and 100mm.
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membrane integrity, and retained structures of ﬁbroblastic and glial
phenotypes respectively. There was no sign of cell lysis, indicating
that the tissue was not cytotoxic (Fig. 5).
Biomechanical testing of the acellular nerves revealed that
decellularisation does have an effect on the biomechanical tensile
properties, with an increase in Young’s modulus, UTS and strain at
UTS (Table II). There was a signiﬁcant increase in the UTS for both
the decellularised peroneal and tibial nerves, as well as strain for
the tibial nerves (P< 0.05) when compared to their native
counterparts. These results were found to be similar in other
Figure 5. Contact cytotoxicity assays of acellular porcine nerves following 48 h culture with normal human fibroblasts and primary rat Schwann cells. The images illustrate
acellular scaffolds as non-cytotoxic to fibroblast and Schwann tested. Cells grow up to and were in physical contact with the acellular nerve for each sample (A & C). Decellularised
scaffold with fibroblasts, scale bar at 100mm and 200 mm respectively; (B & D) Decellularised scaffold with Schwann cells, scale bar¼ 100mm and 200mm respectively; (E)
Cyanoacrylate contact adhesive (positive control) with the arrow indicates cells at, scale bar at 100mm; (F) Collagen gel (negative control), scale bar¼ 100mm.
Table III. Commercially available xenogeneic ECM scaffolds from varying source tissues and species.
Source tissue Source species Products
Dermis Porcine StratticeTM (Lifecell), XenMatrixTM (Bard Davol)
Dermis Bovine TissueMend
1
(Stryker), Veritas
1
(Synovis)
Pericardium Equine OrtAdapt
1
(Synovis)
Pericardium Bovine CopiOs
1
(Zimmer Inc), Perimount
1
(Edwards Lifesciences)
Small intestine Porcine Surgisis
1
(Cook Biotech), Restore
1
(DePuy Orthopaedics), FortaFlex
1
(Integra LifeSciences)
Urinary bladder Porcine MatriStem
1
(ACell)
Reproduced from (Badylak, 2014).
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decellularisation studies (Abdelgaied et al., 2015; Stapleton et al.,
2008; Williams et al., 2009). As previously discussed, elastin and
collagen ﬁbres contribute to the mechanical properties native
nerves (Mason and Phillips, 2011; Tassler et al., 1994). During the
decellularisation process the tissue becomes “looser” due to cell
removal and the collagen ﬁbre network starts to uncrimp (Williams
et al., 2009). Uncrimping or relaxation of the collagen ﬁbres has
been associated with increased stiffness in soft tissues (Freed and
Doehring, 2005). In addition increased ﬁbre mobility due to the less
compact nature of the acellular tissue allow collagen ﬁbres to
reorient easily towards the direction of applied strain, which would
lead to increased stiffness (Williams et al., 2009).
In conclusion, porcine peripheral nerve was successfully
decellularised using a low concentration SDS, hypotonic method.
The acellular nerve retained its native 3D endoneurial microstruc-
ture and mechanical properties while eliminating over 95% of the
cellular components. Characterisation of the ECM revealed
preservation and retention of important ECM components
including collagen, laminin and ﬁbronectin. The data presented
demonstrates that acellular porcine nerves may have potential
clinical utility as a graft to restore motor and sensory function
following injury.
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